Summary of Purpose
This study evaluates the addition of Ginkgo Diterpene Lactone Meglumine Injection to aspirin in the treatment of acute ischemic stroke.Half of patient will receive Ginkgo Diterpene Lactone Meglumine Injection(25mg once/day D1-D14) and aspirin(300mg loading dose,then 100mg once/day D2-D14) in combination, while the other half will receive aspirin(300mg loading dose,then 100mg once/day D2-D14).Read More →
The following dates are available for this trial. Trial information last updated on 13 July 2017.
|15 Jul 2017||5 Jul 2017||31 Oct 2017||31 Dec 2017||1 May 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|